Our commercial partner, Appistry, is announcing a webinar on the commercialization of GATK. They will discuss the Broad-Appistry relationship, the current status of the commercial GATK product (including licensing options), and plans for the future (including expansion to other Broad tools, with a focus on cancer research).
You can register for this free webinar, which is open to all (not just current license holders) on Appistry's website.
As announced a few months ago, commercial users of the GATK will now be required to purchase a license in order to use the full-version GATK 2 for commercial / for-profit use (while GATK-Lite can still be used for any purpose without a license).
We are now able to give you more details about how this will work: we have selected a company called Appistry to be the exclusive partner who will handle for-profit GATK licensing and support. If you have any questions, please visit their FAQs page, and contact them directly to inquire about pricing or any "special case" scenario you feel may apply to your use of the GATK.
Appistry will launch a discussion forum within the next few days in which you will be able to network with your peers and Appistry staff about the for-profit release of the GATK.
If you would like to discuss why we have made these changes to the licensing model, please see our own discussion thread on licensing and source code models in GATK 2.